Elan, Ahold’s audit woes

news

By Hardeep Dhillon

Investors in Irish drug company Elan and Dutch retailer Royal Ahold have been biting their nails waiting to receive the companies’ 2002 accounts, which should be released this month.

Elan is in a race against time to file its 2002 US accounts, after missing its fourth deadline and having to pay bondholders $2.1 million for a one-week reprieve until August 22, as reported at time of going to press.

Elan’s failure

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: